These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 12397547

  • 1. [Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].
    Schmid C, Weisser M, Ledderose G, Stötzer O, Schleuning M, Kolb HJ.
    Dtsch Med Wochenschr; 2002 Oct 18; 127(42):2186-92. PubMed ID: 12397547
    [Abstract] [Full Text] [Related]

  • 2. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
    Hirabayashi N, Goto S, Ishii M, Yuge M, Mitsuma A, Noda N.
    Bone Marrow Transplant; 1998 Jun 18; 21(11):1079-83. PubMed ID: 9645568
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease.
    Weisser M, Schleuning M, Ledderose G, Rolf B, Schnittger S, Schoch C, Schwerdtfeger R, Kolb HJ.
    Bone Marrow Transplant; 2004 Dec 18; 34(12):1083-8. PubMed ID: 15489879
    [Abstract] [Full Text] [Related]

  • 5. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
    Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ.
    J Clin Oncol; 2005 Aug 20; 23(24):5675-87. PubMed ID: 16110027
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun 20; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.
    Bornhäuser M, Kröger N, Schwerdtfeger R, Schafer-Eckart K, Sayer HG, Scheid C, Stelljes M, Kienast J, Mundhenk P, Fruehauf S, Kiehl MG, Wandt H, Theuser C, Ehninger G, Zander AR, Cooperative German Transplant Study Group.
    Eur J Haematol; 2006 Jan 20; 76(1):9-17. PubMed ID: 16343266
    [Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun 20; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 9. Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment.
    Blaise DP, Michel Boiron J, Faucher C, Mohty M, Bay JO, Bardoux VJ, Perreau V, Coso D, Pigneux A, Vey N.
    Cancer; 2005 Nov 01; 104(9):1931-8. PubMed ID: 16178004
    [Abstract] [Full Text] [Related]

  • 10. Total-body irradiation--role and indications: results from the German Registry for Stem Cell Transplantation (DRST).
    Heinzelmann F, Ottinger H, Müller CH, Allgaier S, Faul C, Bamberg M, Belka C.
    Strahlenther Onkol; 2006 Apr 01; 182(4):222-30. PubMed ID: 16622624
    [Abstract] [Full Text] [Related]

  • 11. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia].
    Liu QF, Sun J, Xu D, Zhang Y, Fan ZP, Wei YQ, Meng FY, Zhou SY.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct 01; 24(10):1117-9. PubMed ID: 15485779
    [Abstract] [Full Text] [Related]

  • 12. [Effectiveness of allogeneic bone marrow transplantation in patients with acute leukemia in complete remission and in patients with chronic myeloid leukemia during the chronic phase].
    Liubimova LS, Savchenko VG, Mendeleeva LP, Kliasova GA, Gribanova EO, Demidova IA, Gal'tseva IV, Kuz'mina LA, Momotiuk KS, Kuliev RG.
    Ter Arkh; 1999 Oct 01; 71(7):27-32. PubMed ID: 10481864
    [Abstract] [Full Text] [Related]

  • 13. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H.
    Biol Blood Marrow Transplant; 2009 Nov 01; 15(11):1376-85. PubMed ID: 19822296
    [Abstract] [Full Text] [Related]

  • 14. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
    Cook G, Clark RE, Crawley C, Mackinnon S, Russell N, Thomson K, Pearce RM, Towlson K, Marks DI.
    Biol Blood Marrow Transplant; 2006 Mar 01; 12(3):293-300. PubMed ID: 16503498
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia].
    Liu QF, Fan ZP, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov 01; 24(11):1227-9, 1241. PubMed ID: 15567763
    [Abstract] [Full Text] [Related]

  • 16. Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma.
    Cogle CR, Moreb JS, Leather HL, Finiewicz KJ, Khan SA, Reddy VS, Wingard JR.
    Am J Hematol; 2003 Jul 01; 73(3):169-75. PubMed ID: 12827653
    [Abstract] [Full Text] [Related]

  • 17. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
    Huisman C, Meijer E, Petersen EJ, Lokhorst HM, Verdonck LF.
    Biol Blood Marrow Transplant; 2008 Feb 01; 14(2):181-6. PubMed ID: 18215778
    [Abstract] [Full Text] [Related]

  • 18. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry.
    Faber E, Koza V, Vitek A, Mayer J, Sedlacek P, Zak P, Zapletalova J, Benesova K, Krejcova H, Steinerova K, Maresova I, Cetkovsky P, Czech National Hematopoietic Stem Cell Transplantation Registry.
    Neoplasma; 2007 Feb 01; 54(5):443-6. PubMed ID: 17688375
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic haemopoietic stem cell transplantation using non-myeloablative conditioning--a local experience.
    Leong CF, Cheong SK, Fadilah SA, Ainoon O, Hamidah NH.
    Med J Malaysia; 2003 Jun 01; 58(2):229-35. PubMed ID: 14569743
    [Abstract] [Full Text] [Related]

  • 20. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V.
    Natl Med J India; 2003 Jun 01; 16(1):16-21. PubMed ID: 12715951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.